Taysha Gene Therapies (TSHA) Stock
Taysha Gene Therapies (TSHA) closed at $4.00 on Nov 17, 2026; its Tenet Score is 58 of 100 against 340 Healthcare peers.
30 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $4.00
- Nov 17, 2026
- Market cap
- $1.3B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 3.46 – 7.30
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 58/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Taysha Gene Therapies Inc scores 58/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 58 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatmen…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Intellia Therapeutics IncNTLA | 41 | $1.4B |
| UroGen Pharma LtdURGN | 44 | $1.4B |
| AlvotechALVO | 41 | $1.4B |
| AnaptysBio IncANAB | 53 | $1.4B |
| Novavax, Inc.NVAX | 37 | $1.3B |
| Ocular Therapeutix IncOCUL | 51 | $1.3B |
| Innoviva IncINVA | 73 | $1.3B |
| Absci CorpABSI | 39 | $1.3B |
| Mineralys Therapeutics IncMLYS | 55 | $1.3B |
| Mannkind CorpMNKD | 29 | $1.3B |
Common questions
What sector and industry is Taysha Gene Therapies in?
Taysha Gene Therapies is in the Healthcare sector and the Drugs industry.
What is Taysha Gene Therapies' Tenet Score?
Taysha Gene Therapies' Tenet Score is 58 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




